These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 1720468)
1. Flow cytometric assessment of platelet function in patients with peripheral arterial occlusive disease. Galt SW; McDaniel MD; Ault KA; Mitchell J; Cronenwett JL J Vasc Surg; 1991 Dec; 14(6):747-55; discussion 755-6. PubMed ID: 1720468 [TBL] [Abstract][Full Text] [Related]
2. Conditions influencing release of granule contents from human platelets in citrated plasma induced by ADP or the thrombin receptor activating peptide SFLLRN: direct measurement of percent release of beta-thromboglobulin and assessment by flow cytometry of P-selectin expression. Rand ML; Perry DW; Packham MA; Gemmell CH; Yeo EL; Kinlough-Rathbone RL Am J Hematol; 1996 Aug; 52(4):288-94. PubMed ID: 8701947 [TBL] [Abstract][Full Text] [Related]
3. A fluorescence-conjugated immunobinding assay for the detection of P-selectin on platelets. Wen D; Nguyen TT; Plumhoff EA; Pineda AA; Bowie EJ; Kottke BA J Lab Clin Med; 1994 Sep; 124(3):447-54. PubMed ID: 7521896 [TBL] [Abstract][Full Text] [Related]
4. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation. Sbrana S; Della Pina F; Rizza A; Buffa M; De Filippis R; Gianetti J; Clerico A Cytometry B Clin Cytom; 2008 Jan; 74(1):30-9. PubMed ID: 17630652 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms underlying increased platelet reactivity in patients with peripheral arterial disease. Preliminary results. Reininger CB; Boeger CA; Steckmeier B; Spannagl M; Scweiberer L Int Angiol; 1999 Jun; 18(2):163-70. PubMed ID: 10424375 [TBL] [Abstract][Full Text] [Related]
6. Abnormal typical pattern of platelet function and thromboxane generation in unstable angina. Zahavi M; Zahavi J; Schafer R; Firsteter E; Laniado S Thromb Haemost; 1989 Nov; 62(3):840-5. PubMed ID: 2531938 [TBL] [Abstract][Full Text] [Related]
7. Enhanced platelet release reaction, shortened platelet survival time and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease. Zahavi J; Zahavi M Thromb Haemost; 1985 Feb; 53(1):105-9. PubMed ID: 3158092 [TBL] [Abstract][Full Text] [Related]
8. Platelet activation during steady state sickle cell disease. Westwick J; Watson-Williams EJ; Krishnamurthi S; Marks G; Ellis V; Scully MF; White JM; Kakkar VV J Med; 1983; 14(1):17-36. PubMed ID: 6224876 [TBL] [Abstract][Full Text] [Related]
9. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease. Klinkhardt U; Bauersachs R; Adams J; Graff J; Lindhoff-Last E; Harder S Clin Pharmacol Ther; 2003 Mar; 73(3):232-41. PubMed ID: 12621388 [TBL] [Abstract][Full Text] [Related]
10. The impact of peripheral arterial disease on circulating platelets. McBane RD; Karnicki K; Miller RS; Owen WG Thromb Res; 2004; 113(2):137-45. PubMed ID: 15115669 [TBL] [Abstract][Full Text] [Related]
11. The periodontal anaerobe Porphyromonas gingivalis induced platelet activation and increased aggregation in whole blood by rat model. Yu KM; Inoue Y; Umeda M; Terasaki H; Chen ZY; Iwai T Thromb Res; 2011 May; 127(5):418-25. PubMed ID: 21334044 [TBL] [Abstract][Full Text] [Related]
12. Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome. Xiao Z; Théroux P J Am Coll Cardiol; 2004 Jun; 43(11):1982-8. PubMed ID: 15172401 [TBL] [Abstract][Full Text] [Related]
13. Effect of physiologic shear stresses and calcium on agonist-induced platelet aggregation, secretion, and thromboxane A2 formation. Viisoreanu D; Gear A Thromb Res; 2007; 120(6):885-92. PubMed ID: 17306868 [TBL] [Abstract][Full Text] [Related]
14. Increased platelet purinergic sensitivity in peripheral arterial disease--a pilot study. Braun OO; Jagroop A; Wang L; Mikhailidis DP; Burnstock G; Erlinge D Platelets; 2005 Aug; 16(5):261-7. PubMed ID: 16011976 [TBL] [Abstract][Full Text] [Related]
15. Altered platelet reactivity in peripheral vascular disease complicated with elevated plasma homocysteine levels. Riba R; Nicolaou A; Troxler M; Homer-Vaniasinkam S; Naseem KM Atherosclerosis; 2004 Jul; 175(1):69-75. PubMed ID: 15186948 [TBL] [Abstract][Full Text] [Related]
16. Effects of recombinant human granulocyte-macrophage colony-stimulating factor on platelet survival and activation using a nonhuman primate model. Tomer A; Stahl CP; McClure HM; Anderson DC; Myers LA; Liehl E; Winton EF Exp Hematol; 1993 Nov; 21(12):1577-82. PubMed ID: 8405239 [TBL] [Abstract][Full Text] [Related]
17. Platelet P-selectin plays an important role in arterial thrombogenesis by forming large stable platelet-leukocyte aggregates. Yokoyama S; Ikeda H; Haramaki N; Yasukawa H; Murohara T; Imaizumi T J Am Coll Cardiol; 2005 Apr; 45(8):1280-6. PubMed ID: 15837262 [TBL] [Abstract][Full Text] [Related]
18. Flow cytometric measurement of platelet-leukocyte aggregates: a possible target to monitor platelet function? Klinkhardt U; Harder S Semin Thromb Hemost; 2005; 31(4):400-3. PubMed ID: 16149016 [TBL] [Abstract][Full Text] [Related]
19. Platelet function alterations and their relation to P-selectin (CD62P) expression in children with iron deficiency anemia. Yıldırım ZK; Orhan MF; Büyükavcı M Blood Coagul Fibrinolysis; 2011 Mar; 22(2):98-101. PubMed ID: 21245745 [TBL] [Abstract][Full Text] [Related]
20. Platelet activation markers in patients with peripheral arterial disease--a prospective comparison of different platelet function tests. Gresele P; Catalano M; Giammarresi C; Volpato R; Termini R; Ciabattoni G; Nenci GG; Davì G Thromb Haemost; 1997 Dec; 78(6):1434-7. PubMed ID: 9423790 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]